Literature DB >> 10686538

Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer.

J H Martin1, S Begum, O Alalami, A Harrison, K W Scott.   

Abstract

Nitric oxide is produced by several isoenzymes which are present in many different tissues. We have recently reported the presence of inducible nitric oxide synthase in a breast cancer cell line. The purpose of this study was to examine the distribution of endothelial nitric oxide synthase (eNOS) in a series of human breast tumours. Immunohistochemical investigations demonstrated immunolabelling of tumour cells with the primary antibody, bovine endothelial anti-nitric oxide synthase. Although there was no correlation between eNOS staining and tumour size, there was a significant (p < 0.005) negative correlation (rho = -0.65) between the percentage of tumour cells staining positive for eNOS and the histologic grade of the tumour; there was also a significant (p < 0.05) negative correlation (rho = -0.40) between the percentage of tumour cells staining positive for eNOS and the number of positive lymph nodes. A significant (p < 0.005) positive correlation (rho = 0.63) between the percentage of tumour cells staining positive for eNOS and estrogen receptor (ER) expression by the tumour was also observed. In conclusion, our results demonstrate that eNOS is expressed by human breast tumours and that its presence negatively correlates with histologic grade and lymph node status and positively correlates with ER expression. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686538     DOI: 10.1159/000030114

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  11 in total

1.  Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.

Authors:  S P Hussain; K Raja; P A Amstad; M Sawyer; L J Trudel; G N Wogan; L J Hofseth; P G Shields; T R Billiar; C Trautwein; T Hohler; P R Galle; D H Phillips; R Markin; A J Marrogi; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 2.  NO to breast: when, why and why not?

Authors:  Shehla Pervin; Gautam Chaudhuri; Rajan Singh
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 3.  Cancer cell metabolism and the modulating effects of nitric oxide.

Authors:  Ching-Fang Chang; Anne R Diers; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-11-22       Impact factor: 7.376

4.  Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.

Authors:  G M K Tse; F C Wong; A K H Tsang; C S Lee; P C W Lui; A W I Lo; B K B Law; R A Scolyer; R Z Karim; T C Putti
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

5.  Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents.

Authors:  A Patel; C Fenton; R Terrell; P A Powers; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

6.  A DNA-based fluorescent probe maps NOS3 activity with subcellular spatial resolution.

Authors:  Junyi Zou; Aneesh T Veetil; Maulik S Jani; Yamuna Krishnan
Journal:  Nat Chem Biol       Date:  2020-03-09       Impact factor: 15.040

7.  Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide.

Authors:  Douglas D Thomas; Michael Graham Espey; Lisa A Ridnour; Lorne J Hofseth; Daniele Mancardi; Curtis C Harris; David A Wink
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-03       Impact factor: 11.205

8.  Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.

Authors:  Ji-Yeob Choi; William E Barlow; Kathy S Albain; Chi-Chen Hong; Javier G Blanco; Robert B Livingston; Warren Davis; James M Rae; I-Tien Yeh; Laura F Hutchins; Peter M Ravdin; Silvana Martino; Alan P Lyss; C Kent Osborne; Martin D Abeloff; Daniel F Hayes; Christine B Ambrosone
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

9.  High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer.

Authors:  Baoying Yuan; Changshun Wu; Xingwen Wang; Dan Wang; Huiling Liu; Ling Guo; Xiang-An Li; Junqing Han; Hong Feng
Journal:  Tumour Biol       Date:  2015-10-11

Review 10.  Nitric Oxide and S-Nitrosylation in Cancers: Emphasis on Breast Cancer.

Authors:  Deepshikha Mishra; Vaibhav Patel; Debabrata Banerjee
Journal:  Breast Cancer (Auckl)       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.